Journey Medical Corp
NASDAQ:DERM

Watchlist Manager
Journey Medical Corp Logo
Journey Medical Corp
NASDAQ:DERM
Watchlist
Price: 7.47 USD -1.19% Market Closed
Market Cap: 149.4m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

DERM Price Targets Summary
Journey Medical Corp

Wall Street analysts forecast DERM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DERM is 10.07 USD with a low forecast of 9.09 USD and a high forecast of 11.55 USD.

DERM Lowest Forecast
Wall Street Target
9.09 USD
22% Upside
DERM Average Forecast
Wall Street Target
10.07 USD
35% Upside
DERM Highest Forecast
Wall Street Target
11.55 USD
55% Upside
Lowest
Price Target
9.09 USD
22% Upside
Average
Price Target
10.07 USD
35% Upside
Highest
Price Target
11.55 USD
55% Upside
Journey Medical Corp Competitors:
Price Targets
NEU
Neuren Pharmaceuticals Ltd
131% Upside
SOLARA
Solara Active Pharma Sciences Ltd
13% Upside
DMP
Dermapharm Holding SE
24% Upside
000999
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
29% Upside
NEU
Neuren Pharmaceuticals Ltd
131% Upside
SOLARA
Solara Active Pharma Sciences Ltd
13% Upside
DMP
Dermapharm Holding SE
24% Upside
000999
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
29% Upside
H
195940
HK Inno.N Corp
39% Upside
4503
Astellas Pharma Inc
35% Upside
600332
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
3% Upside
688321
Shenzhen Chipscreen Biosciences Co Ltd
127% Upside

Revenue
Forecast

Revenue Estimate
Journey Medical Corp

For the last 4 years the compound annual growth rate for Journey Medical Corp's revenue is 6%. The projected CAGR for the next 3 years is 41%.

6%
Past Growth
41%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Journey Medical Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Journey Medical Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
What are analyst estimates?

See Also

Summary
DERM intrinsic value, competitors valuation, and company profile.
DCF Valuation
DERM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DERM stock valuation using valuation multiples.
Wall Street Estimates
DERM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DERM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DERM's stock price target?
Price Target
10.07 USD

According to Wall Street analysts, the average 1-year price target for DERM is 10.07 USD with a low forecast of 9.09 USD and a high forecast of 11.55 USD.

What is Journey Medical Corp's Revenue forecast?
Projected CAGR
41%

For the last 4 years the compound annual growth rate for Journey Medical Corp's revenue is 6%. The projected CAGR for the next 3 years is 41%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 249,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.